08:00 , Nov 8, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Alzheimer's disease (AD) Solute carrier family 25 member 38 (SLC25A38); b-amyloid 42 Human and rodent studies suggest inhibiting SLC25A38 could prevent neurodegeneration in AD. In...